Human helicase DDX3 as target for broad-spectrum antivirals against pandemic and emerging viruses

• Annalaura Brai,
• Roberta Fazi,
• Cristina Tintori,
• Josè Estè,
• Roger Badia,
• Sandra Franco,
• Miguel A. Martinez,
• Javier Martinez,
• Andreas Meyerhans,
• Francesco Saladini,
• Maurizio Zazzi,
• Anna Garbelli,
• Maurizio Botta,
• Giovanni Maga

Affiliations

Annalaura Brai

Siena University, Biotechnology, Chemistry and Pharmacology Department, Italy

Roberta Fazi

Siena University, Biotechnology, Chemistry and Pharmacology Department, Italy

Cristina Tintori

Siena University, Biotechnology, Chemistry and Pharmacology Department, Italy

Josè Estè

University Hospital Germans Trias i Pujol, AIDS Research Institute IrsiCaixa, Barcelona, Spain

Roger Badia

University Hospital Germans Trias i Pujol, AIDS Research Institute IrsiCaixa, Barcelona, Spain

Sandra Franco

University Hospital Germans Trias i Pujol, AIDS Research Institute IrsiCaixa, Barcelona, Spain

Miguel A. Martinez

University Hospital Germans Trias i Pujol, AIDS Research Institute IrsiCaixa, Barcelona, Spain

Javier Martinez

Pompeu Fabra University, Infection Biology Group, Dept. of Experimental and Health Sciences, Barcelona, Spain

Andreas Meyerhans

Pompeu Fabra University, Infection Biology Group, Dept. of Experimental and Health Sciences, Barcelona, Spain; ICREA, Barcelona, Spain

Francesco Saladini

Siena University, Medical biotechnology Department, Siena, Italy

Maurizio Zazzi

Siena University, Medical biotechnology Department, Siena, Italy

Anna Garbelli

Molecular Genetics Institute, Pavia, Italy

Maurizio Botta

Siena University, Biotechnology, Chemistry and Pharmacology Department, Italy

Giovanni Maga

Molecular Genetics Institute, Pavia, Italy